Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Combining RU58841 and minoxidil significantly increases hair growth.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Minoxidil effectively treats severe hypertension but has notable side effects.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

A new treatment using special microneedles and a nitric oxide-releasing drug could improve hair growth and be more convenient for people with hair loss.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

The polyherbal emulgel is a promising treatment for rheumatoid arthritis with effective and sustained results.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Certain herbal compounds might help prevent hair loss in menopausal women by activating Vitamin D receptors.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Different enzymes are active in different parts of developing mouse organs.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.